Alan Harris

Title: Alan Harris: Innovator in Pharmaceutical Compositions

Introduction

Alan Harris is a notable inventor based in Malmo, Sweden. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of nasal administration methods and stabilized peptide formulations. With a total of 2 patents, his work has the potential to impact the management of various urinary disorders.

Latest Patents

Harris's latest patents include a composition for nasal administration of desmopressin. This aqueous composition is designed for spray nasal administration of a synthetic analog of vasopressin, containing between 2.5 and 7.5 µg per 100 µl. The formulation may also include an osmotic-pressure controlling agent, such as sodium chloride, a preservative like chlorobutanol or benzalkonium chloride, and a buffer to stabilize the pH between about 4 and 6. Additionally, he has developed a stabilized pharmaceutical peptide composition that comprises a biologically active peptide, a buffer, a quaternary amine-type preservative or disinfectant, and an osmotic pressure-controlling agent. This composition can be stored and used at room temperature, protecting the peptide from adhering to container surfaces.

Career Highlights

Alan Harris is associated with Ferring AB, a company known for its innovative pharmaceutical products. His work at Ferring AB has allowed him to focus on developing advanced therapeutic solutions that address critical health issues.

Collaborations

Harris collaborates with Birgitta Tennhammar-Ekman, contributing to the advancement of pharmaceutical research and development.

Conclusion

Alan Harris is a distinguished inventor whose work in pharmaceutical compositions is paving the way for improved treatment options. His innovative approaches to nasal administration and peptide stabilization are noteworthy contributions to the field.